ROSE PHARMA A/S: Financial statements 2013
CVR: 27174965
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ROSE PHARMA A/S (CVR 27174965) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -129,734 and a net result of DKK -133,626 compared with DKK -335,146 the year before. Equity in the 2013 report amounted to DKK 968,314. The solvency ratio was 66.9%.
- Gross Profit
- DKK -129,734
- Profit/Loss
- DKK -133,626
- Equity
- DKK 968,314
- Total Assets
- DKK 1,446,987
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -130 t. | -134 t. | 968 t. | - |
| 2012 | - | -335 t. | -335 t. | 1.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ROSE PHARMA A/S has published its annual report for 2012. Gross profit came to DKK -335,391, and the net result was DKK -335,146.
About ROSE PHARMA A/S
ROSE PHARMA A/S was a Danish company of the type Aktieselskab based in Roskilde, founded in 2003. The company has been dissolved on 23 April 2020. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GASTROTECH PHARMA A/S and GASTROTECH A/S. The company has 1 employee (2007). In 2016, the company reported a gross profit of DKK -35,218 and a net result of DKK -51,821 compared with DKK -186,905 the year before. Equity in the 2016 report amounted to DKK 979,327.